Funding for this research was provided by:
Qatar National Research Fund (NPRP No. 6-273-3-067)
Received: 22 May 2019
Accepted: 24 September 2019
First Online: 10 October 2019
Ethics approval and consent to participate
: This intervention study was conducted at Hamad Medical Corporation (HMC) in Doha, Qatar and the research ethics board of HMC approved the protocol. A written informed consent was obtained from all participants at enrollment.
: There is no identifiable information of the trial participants in the present manuscript, therefore it is not applicable.
: The authors declare that they have no competing interests.